Integra Lifesciences market cap IART
Share price times shares outstanding: what the whole company sells for, since 2010.
- Today, Nov 2, 2026
- $1.1B
- Highest close in our data
- $6.4B
- Sep 2021
Integra Lifesciences is worth $1.1B at the close on Nov 2, 2026, at $13.61 a share.
That is up 13% over the last year and down 83% over five years.
Its highest close in our data was $6.4B in Sep 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.1B | $696.8M | $1.5B | +8% |
| 2025 | $983M | $864.9M | $2B | −43% |
| 2024 | $1.7B | $1.3B | $3.5B | −49% |
| 2023 | $3.4B | $2.7B | $5B | −27% |
| 2022 | $4.7B | $3.5B | $5.8B | −17% |
| 2021 | $5.7B | $5.3B | $6.4B | +4% |
| 2020 | $5.5B | $3.2B | $5.6B | +9% |
| 2019 | $5B | $3.8B | $5.4B | +33% |
| 2018 | $3.8B | $3.7B | $5.6B | +1% |
| 2017 | $3.8B | $1.6B | $4.2B | +134% |
| 2016 | $1.6B | $1.4B | $3.3B | −36% |
| 2015 | $2.5B | $1.8B | $2.5B | +42% |
| 2014 | $1.8B | $1.3B | $1.8B | +31% |
| 2013 | $1.3B | $911.6M | $1.4B | +30% |
| 2012 | $1B | $656.9M | $1.1B | +25% |
| 2011 | $826.9M | $777M | $1.5B | −38% |
| 2010 | $1.3B | $1.1B | $1.4B | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest Integra Lifesciences' size, closest first, today.
| Company | Market cap |
|---|---|
| IARTIntegra Lifesciences | $1.1B |
| IRMDIradimed | $1B |
| BVSBioventus | $1.1B |
| STAAStaar Surgical | $1.3B |
| CDRECadre | $1.3B |
| EYENational Vision | $1.4B |
| MOVMovado | $710.9M |
| LMATLemaitre Vascular | $1.9B |
| INSPInspire Medical Systems | $1.9B |
| TCMDTactile Systems Technology | $518.1M |
| UFPTUFP Technologies | $2.2B |
| Peer median | $1.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Integra Lifesciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.